Literature DB >> 22534419

Symptom dimensions are associated with progressive brain volume changes in schizophrenia.

G Collin1, E M Derks, N E M van Haren, H G Schnack, H E Hulshoff Pol, R S Kahn, W Cahn.   

Abstract

BACKGROUND: There is considerable variation in progressive brain volume changes in schizophrenia. Whether this is related to the clinical heterogeneity that characterizes the illness remains to be determined. This study examines the relationship between change in brain volume over time and individual variation in psychopathology, as measured by five continuous symptom dimensions (i.e. negative, positive, disorganization, mania and depression).
METHODS: Global brain volume measurements from 105 schizophrenia patients and 100 healthy comparison subjects, obtained at inclusion and 5-year follow-up, were used in this study. Symptom dimension scores were calculated by factor analysis of clinical symptoms. Using linear regression analyses and independent-samples t-tests, the relationship between symptom dimensions and progressive brain volume changes, corrected for age, gender and intracranial volume, was examined. Antipsychotic medication, outcome and IQ were investigated as potential confounders.
RESULTS: In patients, the disorganization dimension was associated with change in total brain (β=-0.295, p=0.003) and cerebellar (β=-0.349, p<0.001) volume. Furthermore, higher levels of disorganization were associated with lower IQ, irrespective of psychiatric status (i.e. patient or control). In healthy comparison subjects, disorganization score was not associated with progressive brain volume changes.
CONCLUSION: Heterogeneity in progressive brain volume changes in schizophrenia is particularly associated with variation in disorganization. Schizophrenia patients with high levels of disorganization exhibit more progressive decrease of global brain volumes and have lower total IQ. We propose that these patients form a phenotypically and biologically homogenous subgroup that may be useful for etiological (e.g., genetic) studies.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22534419     DOI: 10.1016/j.schres.2012.03.036

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  10 in total

1.  Symptom dimensions and subgroups in childhood-onset schizophrenia.

Authors:  Kirsten E S Craddock; Xueping Zhou; Siyuan Liu; Peter Gochman; Dwight Dickinson; Judith L Rapoport
Journal:  Schizophr Res       Date:  2017-11-13       Impact factor: 4.939

2.  Psychopathological Syndromes Across Affective and Psychotic Disorders Correlate With Gray Matter Volumes.

Authors:  Frederike Stein; Tina Meller; Katharina Brosch; Simon Schmitt; Kai Ringwald; Julia Katharina Pfarr; Susanne Meinert; Katharina Thiel; Hannah Lemke; Lena Waltemate; Dominik Grotegerd; Nils Opel; Andreas Jansen; Igor Nenadić; Udo Dannlowski; Axel Krug; Tilo Kircher
Journal:  Schizophr Bull       Date:  2021-10-21       Impact factor: 9.306

3.  The identification of family subtype based on the assessment of subclinical levels of psychosis in relatives.

Authors:  Eske M Derks; Marco P M Boks; Jeroen K Vermunt
Journal:  BMC Psychiatry       Date:  2012-07-03       Impact factor: 3.630

4.  Extensive gray matter volume reduction in treatment-resistant schizophrenia.

Authors:  Valerie M Anderson; Meghan E Goldstein; Robert R Kydd; Bruce R Russell
Journal:  Int J Neuropsychopharmacol       Date:  2015-02-25       Impact factor: 5.176

5.  Plasma levels of 3-methoxy-4-hydroxyphenylglycol are associated with microstructural changes within the cerebellum in the early stage of first-episode schizophrenia: a longitudinal VBM study.

Authors:  Joji Nishimura; Shingo Kakeda; Osamu Abe; Reiji Yoshimura; Keita Watanabe; Naoki Goto; Hikaru Hori; Toru Sato; Hidemasa Takao; Hiroyuki Kabasawa; Jun Nakamura; Yukunori Korogi
Journal:  Neuropsychiatr Dis Treat       Date:  2014-12-08       Impact factor: 2.570

6.  Cognitive and psychopathology correlates of brain white/grey matter structure in severely psychotic schizophrenic inpatients.

Authors:  Nerisa Banaj; Federica Piras; Fabrizio Piras; Valentina Ciullo; Mariangela Iorio; Claudia Battaglia; Donatella Pantoli; Giuseppe Ducci; Gianfranco Spalletta
Journal:  Schizophr Res Cogn       Date:  2018-02-21

7.  The Clock Is Ticking - Brain Atrophy in Case of Acute Trauma?

Authors:  Alexandrina S Nikova; Georgios Sioutas; Konstantinos Kotopoulos; Dimitar Ganchev; Varvara Chatzipaulou; Theodossios Birbilis
Journal:  Korean J Neurotrauma       Date:  2019-10-23

8.  Structural MRI Differences between Patients with and without First Rank Symptoms: A Delusion?

Authors:  Henriette D Heering; Godefridus J C Koevoets; Laura Koenders; Marise W J Machielsen; Carin J Meijer; Manabu Kubota; Jessica de Nijs; Wiepke Cahn; Hilleke E Hulshoff Pol; Lieuwe de Haan; Rene S Kahn; Neeltje E M van Haren
Journal:  Front Psychiatry       Date:  2015-07-29       Impact factor: 4.157

9.  Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies.

Authors:  P Fusar-Poli; R Smieskova; M J Kempton; B C Ho; N C Andreasen; S Borgwardt
Journal:  Neurosci Biobehav Rev       Date:  2013-06-14       Impact factor: 8.989

10.  Facial emotion recognition impairment is related to disorganisation in multi-episode schizophrenia.

Authors:  Anna Comparelli; Antonella De Carolis; Valentina Corigliano; Giada Trovini; Julia Dehning; Simone Di Pietro; Eleonora De Pisa; Silvana Galderisi; Paolo Girardi
Journal:  Schizophr Res Cogn       Date:  2014-08-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.